A portable test identifies populations vulnerable to infectious diseases in remote settings
(American Association for the Advancement of Science) Researchers have created a compact and portable device that can test human blood samples for the presence of antibodies against measles and rubella in only 35 minutes.
[Shabait] Massawa. -At an assessment meeting conducted in Massawa on 17 January it was reported that successful measles and rubella vaccination and Vitamin A distribution was conducted in the Northern Red Sea region.
ConclusionSerological surveillance is important to monitor immune status in population. Susceptibility of young adults to measles, mumps, and rubella indicates need for booster vaccination. With the recent launch of measles-rubella vaccination campaign in India, country specific data will be required to plan periodicity of such campaign, which in turn would be based on accumulation of susceptible individuals in a community. Lastly, inclusion of mumps vaccine in the national universal immunization program needs consideration.
This report explains the UK's strategy towards measles and rubella elimination. It focuses on four core components: achieve and sustain ≥ 95% coverage in the routine childhood programme; achieve ≥ 95% coverage with 2 doses of MMR vaccine in older age cohorts through opportunistic and targeted catch-up; strengthen measles and rubella surveillance; and ensure easy access to high-quality, evidence-based information.
[Shabait] Barentu -At an assessment meeting conducted in Barentu on 13 January it was reported that successful measles and rubella vaccination and Vitamin A distribution was conducted in the Gash Barka region through strong participation of the public and stakeholders. The vaccination program was conducted from 21 to 30 November 2018.
This article discusses ways to overcome the barriers to move varicella forward as a truly vaccine preventable disease.
Public Health England ’s new measles and rubella elimination strategy depicts a future that is free of measles, rubella and congenital rubella syndrome (CRS).
GP practices to help boost MMR uptake Related items fromOnMedica Vaccination plea as measles outbreak continues Childhood vaccine uptake slumps in England Tonsillectomy in childhood raises risk of respiratory diseases GPs put on alert for measles as cases rise
The vaccination rate against measles, mumps and rubella is the lowest it has been since 2011, and needs to be improved to prevent further outbreaks.
CONCLUSION: This large study shows that the proportion of children with delayed vaccination in France was globally high and substantial for Men-C and the first MMR vaccination. Risk of a delayed second and third dose was increased with a delayed first dose, which may reflect vaccine hesitancy. PMID: 30638762 [PubMed - as supplied by publisher]
Conclusion Our survey demonstrates a wide variation regarding the timing of live-attenuated vaccines after autologous HSCT or after immunoglobulin administration and regarding immunization against encapsulated bacteria. Many centers do not adhere to current recommendations. Studies should focus on a detailed analysis of the epidemiology of infections with encapsulated bacteria after pediatric autologous HSCT as well as on the immune recovery and the response to revaccination in this setting. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents |  ...